ArticleCancers2025

Mortalin Represents a Promising Therapeutic Target for Oral Cancers: Clinical Relevance and Experimental Evidence for the Activation of Akt/mTOR Signaling.

Sosmitha Girisa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.